Cilostazol
2025CYFYIRB-BA-113
Approved small_molecule active
Quick answer
Cilostazol for Cerebral Small Vessel Disease is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Cerebral Small Vessel Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- active